1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Diagnoses of brain tumors in the group with NDN and those with HDN^{^a}
Histology NDN (n = 81) (%) HDN (n = 103) (%)
Anaplastic astrocytoma 8 (9.9) 19 (18.4)
Astroblastoma 0 (0.0) 1 (1.0)
Astrocytoma 4 (4.9) 14 (13.6)
Astrocytoma, pilocytic 2 (2.5) 4 (3.9)
Desmoplastic nodular medulloblastoma 0 (0.0) 1 (1.0)
Ependymoma 4 (4.9) 5 (4.9)
Fibrillary astrocytoma 1 (1.2) 4 (3.9)
Gemistocytic astrocytoma 1 (1.2) 0 (0.0)
Giant cell glioblastoma 1 (1.2) 0 (0.0)
Glioblastoma 50 (61.7) 16 (15.5)
Glioma, malignant 4 (4.9) 7 (6.8)
Medulloblastoma 3 (3.7) 7 (6.8)
Medullomyoblastoma 0 (0.0) 1 (1.0)
Mixed glioma 0 (0.0) 3 (2.9)
Myxopapillary ependymoma 0 (0.0) 2 (1.9)
Oligodendroglioma 2 (2.5) 10 (9.7)
Oligodendroglioma, anaplastic 1 (1.2) 7 (6.8)
Pleomorphic xanthoastrocytoma 0 (0.0) 1 (1.0)
Primitive neuroectodermal tumor 0 (0.0) 1 (1.0)
↵a Note the high percentages of glioblastoma multiforme in the NDN group.